CA2020209A1 - Surfactant tres concentre, a faible viscosite - Google Patents

Surfactant tres concentre, a faible viscosite

Info

Publication number
CA2020209A1
CA2020209A1 CA2020209A CA2020209A CA2020209A1 CA 2020209 A1 CA2020209 A1 CA 2020209A1 CA 2020209 A CA2020209 A CA 2020209A CA 2020209 A CA2020209 A CA 2020209A CA 2020209 A1 CA2020209 A1 CA 2020209A1
Authority
CA
Canada
Prior art keywords
low viscosity
highly concentrated
concentrated surfactant
surfactant suspension
surfactant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2020209A
Other languages
English (en)
Other versions
CA2020209C (fr
Inventor
Bernd Disse
Eberhard Weller
Robert Becker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of CA2020209A1 publication Critical patent/CA2020209A1/fr
Application granted granted Critical
Publication of CA2020209C publication Critical patent/CA2020209C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Artificial Filaments (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002020209A 1989-07-04 1990-06-29 Surfactant tres concentre, a faible viscosite Expired - Fee Related CA2020209C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3921954.2 1989-07-04
DE3921954A DE3921954A1 (de) 1989-07-04 1989-07-04 Niedrig-viskose, hochkonzentrierte surfactant-suspension

Publications (2)

Publication Number Publication Date
CA2020209A1 true CA2020209A1 (fr) 1991-01-05
CA2020209C CA2020209C (fr) 2000-09-12

Family

ID=6384269

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002020209A Expired - Fee Related CA2020209C (fr) 1989-07-04 1990-06-29 Surfactant tres concentre, a faible viscosite

Country Status (24)

Country Link
US (1) US5552161A (fr)
EP (1) EP0406732B1 (fr)
JP (1) JP3103582B2 (fr)
KR (1) KR0162642B1 (fr)
AT (1) ATE122891T1 (fr)
AU (1) AU623538B2 (fr)
CA (1) CA2020209C (fr)
DD (1) DD297916A5 (fr)
DE (2) DE3921954A1 (fr)
DK (1) DK0406732T3 (fr)
ES (1) ES2072940T3 (fr)
FI (1) FI95655C (fr)
HK (1) HK1000277A1 (fr)
HU (1) HU205004B (fr)
IE (1) IE68448B1 (fr)
IL (1) IL94961A (fr)
NO (1) NO180620C (fr)
NZ (2) NZ242869A (fr)
PH (1) PH30232A (fr)
PL (1) PL164434B1 (fr)
PT (1) PT94574B (fr)
RU (1) RU2077880C1 (fr)
UA (1) UA26313A (fr)
ZA (1) ZA905182B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US6172203B1 (en) * 1996-02-07 2001-01-09 Alfredo Adolfo Hager Method for extracting and purifying pulmonary surfactant
US7053176B1 (en) 1999-09-16 2006-05-30 Altana Pharma Ag Combination of C1-INH and lung surfactant for the treatment of respiratory disorders
EP1249244A1 (fr) 2001-04-13 2002-10-16 Universiteit Gent Compositions thérapeutiques pour le traitement d'une maladie influencée par l'équilibre G-actin / F-actin, p.e. une maladie respiratoire
AU2002338882B2 (en) 2001-10-11 2008-04-03 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. Novel use of pulmonary surfactant
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
US7776619B2 (en) 2005-05-11 2010-08-17 Yamasa Corporation Method of stabilizing pulmonary surfactant protein
US8048043B2 (en) * 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55160721A (en) * 1979-06-02 1980-12-13 Tokyo Tanabe Co Ltd Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent
EP0110498B2 (fr) * 1982-11-22 1991-09-18 Teijin Limited Surfactant pulmonaire artificiel et remède le contenant comme principe actif pour le syndrome d'insuffisance respiratoire
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
CS938384A1 (en) * 1983-12-08 1990-08-14 Lachmann Burkhardt Pharmaceutical agent for breathlesness therapy and method of its production
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e

Also Published As

Publication number Publication date
PH30232A (en) 1997-02-05
EP0406732A3 (en) 1991-02-27
IE68448B1 (en) 1996-06-26
CA2020209C (fr) 2000-09-12
ES2072940T3 (es) 1995-08-01
JPH0344332A (ja) 1991-02-26
PT94574A (pt) 1991-03-20
NZ242869A (en) 1997-05-26
IL94961A0 (en) 1991-06-10
DE59009113D1 (de) 1995-06-29
NO180620C (no) 1997-05-21
JP3103582B2 (ja) 2000-10-30
UA26313A (uk) 1999-08-30
FI95655C (fi) 1996-03-11
AU623538B2 (en) 1992-05-14
DD297916A5 (de) 1992-01-30
DE3921954A1 (de) 1991-01-17
RU2077880C1 (ru) 1997-04-27
ZA905182B (en) 1992-03-25
PT94574B (pt) 1997-02-28
NO902961D0 (no) 1990-07-03
EP0406732B1 (fr) 1995-05-24
PL164434B1 (pl) 1994-07-29
FI903341A0 (fi) 1990-07-03
IL94961A (en) 1994-10-21
KR910002427A (ko) 1991-02-25
HK1000277A1 (en) 1998-02-20
HU205004B (en) 1992-03-30
KR0162642B1 (ko) 1998-12-01
HU904077D0 (en) 1990-12-28
NO902961L (no) 1991-01-07
NZ234341A (en) 1992-07-28
EP0406732A2 (fr) 1991-01-09
NO180620B (no) 1997-02-10
AU5867690A (en) 1991-01-10
DK0406732T3 (da) 1995-10-02
HUT56274A (en) 1991-08-28
US5552161A (en) 1996-09-03
ATE122891T1 (de) 1995-06-15
IE902408A1 (en) 1991-06-19
FI95655B (fi) 1995-11-30

Similar Documents

Publication Publication Date Title
TW329059B (en) Silica
ES8607727A1 (es) Procedimiento para la estabilizacion de preparados farmaceuticos en forma de suspensiones conteniendo sucralfato
AU2755592A (en) Air purifying respirator suspension
AU2452088A (en) Plasma and recombinant protein formulations in high ionic strength media
CA2020209A1 (fr) Surfactant tres concentre, a faible viscosite
GEP19971155B (en) Contrast medium and method for its production
GR3007326T3 (fr)
RU97113691A (ru) Противовосполительные глазные капли
EP2241329A3 (fr) Anticorps anti-interleukin-9 ou anticorps du récepteur anti-interleukin-9 pour le traitment de la hyper-réponse bronchique
GR3002388T3 (en) Stable aqueous suspension concentrate composition
AU589970B2 (en) Animal litter and process for the production thereof
MY115710A (en) Desiccant composition
FR2677351B1 (fr) Suspension aqueuse concentree d'hydrate de calcium et son procede de preparation.
GB9101463D0 (en) Treatment of poisoning and compositions for use therein
AU7465298A (en) Process of increasing calcium content in an aqueous solution
NZ227408A (en) Topical pharmaceutical compositions containing dithranol
AU3703795A (en) Chondrocyte cell-lines
GB2308830B (en) Air suspension system safety feature against fracture of the trailing arm
PL272154A1 (en) Apparatus for aqueous suspension and solution of calcium in particular of quicklime
AU4320389A (en) Improvements in or relating to ceiling suspension arrangements
GB2228399B (en) Process for enhancing the perceived strength of tobacco smoke
EG18716A (en) Aqueous suspension concentrate compositions
MX9706361A (es) Sales de carboxiamidas estables, de accion prolongada, composiciones que las contienen y el uso de las mismas.
PT101461A (pt) Nutriente liquido para recem-nascidos nutriente liquido para recem-nascidos
BG102009A (en) Method for the treatment of manic and two-pole disease

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed